Business

United States

Samsung Biologics to Raise $2.2 Billion to Fund PolyPeptide Deal

Bloomberg

by Youkyung Lee and Denny Thomas

Aug 28, 2026 · 7:07 AM

0 views

Samsung Biologics to Raise $2.2 Billion to Fund PolyPeptide Deal

Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.

Continue Reading on Bloomberg

This article is aggregated from Bloomberg. Click below to read the full story.

Read Full Story

🏷️ Topics: samsung biologics raise billion polypeptide

🔗 Share this story

Twitter Facebook WhatsApp LinkedIn

Related Stories

Venezuela weighs exit from Opec as US discusses stake in oil fields

Venezuela weighs exit from Opec as US discusses stake in oil fields

Business Standard 17m ago

PHP/USD: Philippine Peso Falls Past 62 Per Dollar on Elevated Oil Prices

PHP/USD: Philippine Peso Falls Past 62 Per Dollar on Elevated Oil Prices

Bloomberg 35m ago

Japan Hybrid Bond Revival Driven by Acquisitions, Yield-Chasers

Japan Hybrid Bond Revival Driven by Acquisitions, Yield-Chasers

Bloomberg 38m ago

Oil on track for weekly loss even as Iran tensions simmer

Oil on track for weekly loss even as Iran tensions simmer

Economic Times - Markets 45m ago

China bets on exports of cheap 3D-printed drone killers

China bets on exports of cheap 3D-printed drone killers

Financial Times 46m ago

Barclays Targets India’s Richest 1% in Private Banking Boom

Barclays Targets India’s Richest 1% in Private Banking Boom

Bloomberg 52m ago